On the use and abuse of register studies: the case of menopausal hormone therapy

The EMAS officers have commented on the recent manuscript by Savolainen-Peltonen et al., published on the British Medical Journal in an open access editorial published in Maturitas. This Finnish registry study explored the association between the use of MHT in post-menopausal women and a diagnosis of Alzheimer’s disease (AD). The main finding was that women…

Details

EMAS position statement: predictors of premature and early natural menopause

EMAS has just published a new position statement on predictors of premature and early natural menopause in Maturitas. The key findings are detailed below. Strong genetic predictors of premature and early menopause include a family history of premature or early menopause, being a child of a multiple pregnancy and some specific genetic variants. Women with…

Details